Affiliation:
1. School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, Adelaide, Australia
Abstract
Mucositis is a side effect associated with the use of chemotherapy, and has a significant impact on the
quality of life. Mucositis, by definition, refers to the inflammation of the mucosa and occurs throughout the alimentary
tract from the mouth to anus. Nuclear Factor kappa B (NFκB) encompasses a family of transcription factors,
which upregulate pro-inflammatory cytokines. These are recognized as key targets in developing therapeutic interventions
for chemotherapy-induced mucositis, and cyclooxygenase (COX)-2 inhibition may also be beneficial in
reducing the severity and duration. This review focuses on the pathobiology of chemotherapy-induced oral and gastrointestinal
mucositis and recent research examining the role of agents with anti-inflammatory activity in treatment
and prevention of the condition. We consider agents in clinical use as well as some others under current investigation
including plant-derived and other natural medicines.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献